ORANGE GROVE BIO Trademark
Trademark Overview
On Saturday, March 2, 2024, a trademark application was filed for ORANGE GROVE BIO with the United States Patent and Trademark Office. The USPTO has given the ORANGE GROVE BIO trademark a serial number of 98430599. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, September 18, 2024. This trademark is owned by Orange Grove Bio, LLC. The ORANGE GROVE BIO trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:
Business assistance, advisory and consulting services in the field of business formation services, namely, the formation of biotechnology companies for others; New business venture development and formation consulting services; Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare
Biotechnology research; Medical research; Pharmaceutical drug development services; Providing medical and scientific research information; Research and development in the pharmaceutical and biotechnology fields
General Information
| Serial Number | 98430599 |
| Word Mark | ORANGE GROVE BIO |
| Filing Date | Saturday, March 2, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Wednesday, September 18, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of a tree comprised of nine green shaded hexagons clustered in the shape of the treetop on top of a brown tree trunk with the words ORANGE GROVE BIO in black stacked horizontally on top of each other to the right of the tree. |
| Indication of Colors claimed | The color(s) green, brown and black is/are claimed as a feature of the mark. |
| Goods and Services | Business assistance, advisory and consulting services in the field of business formation services, namely, the formation of biotechnology companies for others; New business venture development and formation consulting services; Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare |
| Goods and Services | Biotechnology research; Medical research; Pharmaceutical drug development services; Providing medical and scientific research information; Research and development in the pharmaceutical and biotechnology fields |
Classification Information
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, March 2, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | Thursday, March 23, 2023 |
| First Use In Commerce Date | Thursday, March 23, 2023 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, March 2, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, March 23, 2023 |
| First Use In Commerce Date | Thursday, March 23, 2023 |
Trademark Owner History
| Party Name | Orange Grove Bio, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cinncinati, OH 45202-4104 |
Trademark Events
| Event Date | Event Description |
| Saturday, March 2, 2024 | NEW APPLICATION ENTERED |
| Sunday, July 14, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Sunday, July 14, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, September 18, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 18, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 18, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, September 18, 2024 | NON-FINAL ACTION WRITTEN |
